Is Hormone Replacement Therapy (HRT) Right for You?
Written & medically reviewed by
Gabrielle Rivera, MSN, APRN, FNP-C
Certified Family Nurse Practitioner · Medical Director

Who is a candidate for hormone replacement therapy — and who isn't? A clear look at eligibility, the timing window, delivery methods, and the honest risk picture.
Related Treatment
Hormone Therapy & HRT in Vancouver, WAIn This Article
Who is a good candidate for hormone replacement therapy?
Generally, women under 60 or within 10 years of their final menstrual period who are experiencing moderate to severe menopausal symptoms — hot flashes, night sweats, sleep disruption, or vaginal dryness — and who do not have a history of breast cancer, blood clots, stroke, coronary artery disease, active liver disease, or unexplained vaginal bleeding.
Candidacy at a glance
A starting framework, not a substitute for individual assessment. Some entries in the right-hand column are absolute; others simply mean the conversation is more nuanced.
Generally a reasonable candidate
- Under 60, or within 10 years of your final period
- Moderate to severe hot flashes or night sweats
- Sleep disruption clearly tied to vasomotor symptoms
- Vaginal dryness or discomfort with intimacy
- Early menopause or primary ovarian insufficiency
- Bone density concerns alongside menopausal symptoms
- Symptoms meaningfully affecting daily function
Not a candidate, or requires specialist input
- History of breast cancer or other hormone-sensitive cancer
- History of blood clots (DVT or pulmonary embolism)
- Prior stroke or heart attack, or known coronary artery disease
- Active liver disease
- Unexplained vaginal bleeding — this must be investigated first
- Known clotting disorder or strong family history of clots
- Pregnancy
Unexplained vaginal bleeding deserves emphasis: it is not simply a contraindication to defer around, it is a symptom that needs investigating on its own merits before any hormone conversation proceeds.
Why timing matters so much
Much of the confusion around HRT traces back to early reporting on the Women's Health Initiative, which studied a population that was on average considerably older and further from menopause than the women typically considering treatment today. Subsequent analysis has shaped current thinking around what is often called the timing hypothesis — that the balance of benefit and risk is generally more favourable when hormone therapy is started nearer to menopause rather than many years after.
In practical terms, that is why the under-60 and within-10-years framing appears so consistently in current guidance. It does not mean treatment is automatically unsafe outside that window, and it does not mean it is automatically safe within it. It means the starting point of the conversation shifts.
It also means that a decision made years ago — by you or by a previous clinician — is worth revisiting. Guidance has changed considerably, and many women were steered away from HRT on the basis of an early interpretation that has since been substantially reconsidered.
Types and delivery methods
Not all hormone therapy is the same, and the differences genuinely matter to the risk picture.
| Type | What it is | Typically used for | Worth knowing |
|---|---|---|---|
| Systemic estrogen | Estrogen circulating throughout the body, via patch, gel, spray, or pill | Hot flashes, night sweats, sleep disruption, bone protection | The main treatment for vasomotor symptoms |
| Combined (estrogen + progestogen) | Estrogen with a progestogen added | Anyone with an intact uterus | The progestogen protects the uterine lining — not optional if you have a uterus |
| Local vaginal estrogen | Low-dose cream, tablet, or ring acting locally | Vaginal dryness, discomfort with intimacy, recurrent urinary symptoms | Minimal systemic absorption — a different risk conversation entirely |
| Transdermal delivery | Patch, gel, or spray absorbed through skin | Systemic symptoms | Bypasses first-pass liver metabolism; generally regarded as carrying a lower clot risk than oral |
| Oral delivery | Tablets taken by mouth | Systemic symptoms | Convenient and well established; different clot risk profile than transdermal |
If dryness is your main symptom
Local vaginal estrogen is worth asking about specifically. Because absorption into the bloodstream is minimal, it is often appropriate for women who are not candidates for systemic HRT — including, in many cases, after discussion with their oncology team. It is frequently the most under-used option in menopause care. See vaginal wellness for the wider picture.
How the decision gets made
What a thorough consultation should actually cover.
- 1
Symptom inventory
Which symptoms, how severe, how long, and how much they affect daily function. Severity and impact matter more than any single symptom's presence.
- 2
Personal and family history
Breast and gynaecological cancer history, clotting events, cardiovascular disease, liver disease, migraine with aura, and family patterns.
- 3
Where you sit in the transition
Still cycling, recently postmenopausal, or many years out — this shapes both suitability and which formulation makes sense.
- 4
Baseline workup
Targeted bloodwork and, where relevant, up-to-date screening. See how to prepare for hormone labs so results are actually interpretable.
- 5
Weighing it together
An honest discussion of what treatment can and cannot do for your particular symptoms, what the risks are in your specific context, and what alternatives exist if HRT is not appropriate.
- 6
Review and reassess
Starting HRT is not a permanent commitment. Response, dose, and continuation are reviewed over time rather than set once.
If HRT isn't right for you
Being outside the candidacy window does not mean nothing can be done, and it is worth saying that plainly because many women hear "no" and stop asking. Non-hormonal prescription options exist for vasomotor symptoms, local vaginal treatment is often still available even when systemic therapy is not, and sleep, resistance training, protein intake, and alcohol reduction all have genuine evidence behind them for symptom burden.
Addressing what else is contributing also matters — thyroid dysfunction, iron deficiency, and sleep disorders all mimic or amplify menopausal symptoms, and each is treatable in its own right.
Hormone therapy in Vancouver, Washington
Eternal Beauty Med Spa & Vitality Clinic provides hormone therapy from our clinic in Vancouver, Washington — Clark County, just north of Portland, near Vancouver Mall — with virtual consultations available for Oregon patients. Directions and hours are on our locations page.
Care is led by Gabrielle Rivera, MSN, APRN, FNP-C, Medical Director for Washington and Oregon. If your history places you outside standard candidacy, we will tell you that directly and discuss what else is available rather than proceeding regardless.
Frequently Asked Questions
Want a straight answer about your own candidacy?
It is a genuinely individual question, and it deserves a proper review of your symptoms and history rather than a general rule. A consultation covers where you sit, what your options are, and what to do if hormone therapy turns out not to be the right fit.
Book a Hormone ConsultationInterested in this treatment?
If you have specific questions about wellness treatments or want to see if Is Hormone Replacement Therapy (HRT) Right for You? is right for you, our expert providers are ready to help.
Request a Consultation


